Brief: Bellicum Presents New Translational Data For BPX-601 at ASCO GI Cancers Symposium
24/01/2020 12:34
Jan 24 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PRESENTS NEW TRANSLATIONAL DATA FOR BPX-601 AT
ASCO GI
CANCERS SYMPOSIUM
* BELLICUM PHARMACEUTICALS INC - BPX-601 GOCAR-T CELLS
EXHIBITED
ENHANCED SURVIVAL AND PERSISTENCE UP TO 9 MONTHS
* BELLICUM PHARMACEUTICALS INC - INITIAL RESULTS FROM COHORT
5C
FOR BPX-601 ARE EXPECTED DURING SECOND HALF OF THIS YEAR
Source text for Eikon: ID:nGNX4bs8fh
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview